Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structure-Based Discovery of Potent BCL-XL Inhibitors through Rescaffolding.

Journal of medicinal chemistry·2026

Same author

Decoupling Product Selectivity in Electrocatalytic CO<sub>2</sub> Reduction by Steering the Interfacial Water Structure.

Journal of the American Chemical Society·2026

Same author

Structure-guided allosteric modulation of the delta opioid receptor.

bioRxiv : the preprint server for biology·2025

Same author

NMR and SPR Fragment-Based Screening Can Produce Novel High Affinity Small Molecule Hits against Structured RNAs.

ACS chemical biology·2025

Same author

G Protein: β-Arrestin Bias Confers Differential Regulation of Gα<sub>q</sub> Signaling by GPR17 Antagonists.

ACS chemical neuroscience·2025

Same author

Discovery of a Cryptic Pocket in EcDsbA Opens New Opportunities for Antibacterial Discovery.

Angewandte Chemie (International ed. in English)·2025

Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026

Same journal

One Face, Three Solutions: Structural Convergence in PD-L1 Inhibition across Antibodies, Macrocycles, and Small Molecules.

Journal of medicinal chemistry·2026

Same journal

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity.

Journal of medicinal chemistry·2026

Same journal

Structure-Based Discovery of (<i>E</i>)- and (<i>Z</i>)-4-Oxobut-2-enoate Derivatives as Novel Covalent Pin1 Inhibitors with Antitumor Activity.

Journal of medicinal chemistry·2026

Same journal

Hybrids of Benzenesulfonamide Oxadiazole Derivatives with Dual CA II and COX-2 Inhibitory Activity Demonstrating Antiglaucoma and Anti-inflammatory Action: Synthesis, In Silico Insights, and In Vitro and In Vivo Bioevaluation.

Journal of medicinal chemistry·2026

Same journal

Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

Journal of medicinal chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Exploiting a Cryptic Pocket in DsbA through Structure-Guided Parallel Synthesis and Direct-to-Biology Screening.

Yildiz Tasdan^1,2, Gautham R Balaji^1,3, James Davidson⁴

¹Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.

Journal of Medicinal Chemistry

|March 6, 2026

Summary

This summary is machine-generated.

Researchers developed potent small-molecule inhibitors targeting the enzyme DsbA, crucial for bacterial virulence. This strategy exploits a cryptic pocket to combat antibacterial resistance and advance antivirulence drug development.

More Related Videos

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Mar 7, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Biochemistry
Structural Biology
Drug Discovery

Background:

Antibacterial resistance is a critical global health threat.
DsbA, a bacterial oxidoreductase, is essential for virulence factor folding and activity.
Inhibiting DsbA offers a strategy to combat bacterial infections and resistance.

Purpose of the Study:

To develop novel small-molecule inhibitors targeting Escherichia coli DsbA.
To explore the potential of DsbA's cryptic pocket as a drug target.
To create potent antivirulence compounds against drug-resistant bacteria.

Main Methods:

Structure-based drug design utilizing X-ray crystallography.
Elaboration of fragments from the DsbA cryptic pocket into the hydrophobic groove.
Parallel synthesis and direct-to-biology screening of compounds.

Main Results:

Identification of the most potent small-molecule inhibitors of E. coli DsbA to date.
Successful design strategy leveraging the cryptic pocket for ligand development.
Demonstration of a novel approach for targeting bacterial virulence.

Conclusions:

Exploiting cryptic pockets in enzymes like DsbA is a viable strategy for drug discovery.
The developed inhibitors represent promising leads for antivirulence therapies.
This work contributes to the fight against antibacterial resistance through novel compound development.